Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

Trinity Biotech Captia Measles IgM Recalled by Clark Laboratories, Inc. (dba,Trinity Biotech USA) Due to The product lot failed to meet QC acceptance...

Date: July 11, 2016
Company: Clark Laboratories, Inc. (dba,Trinity Biotech USA)
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Clark Laboratories, Inc. (dba,Trinity Biotech USA) directly.

Affected Products

Trinity Biotech Captia Measles IgM, REF/Product Code 2326060,Test Kit for 96 Determinations, IVD

Quantity: US: 6 kits, Foreign: 50 kits

Why Was This Recalled?

The product lot failed to meet QC acceptance criteria during stability testing. The Calibrator OD was dropping causing the positive control to be invalid (running high out of range).

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Clark Laboratories, Inc. (dba,Trinity Biotech USA)

Clark Laboratories, Inc. (dba,Trinity Biotech USA) has 9 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report